FINN Partners appoints Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead
Global integrated marketing and communications agency FINN Partners has appointed Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead.
Taylor-Roberts will lead the FINN UK Health Group in strengthening its reputation as a leading communications partner for the biopharma, medical device and health system sectors.
She succeeds Julie Adrian, who returned to her role as head of Alverium Health.
Taylor-Roberts said: “At the heart of great health communications agencies is strategic partnership with clients, built on deep insight into, and understanding of stakeholders and audiences, sector challenges, and business opportunities.
“Integrated marketing communication is a powerful tool for companies striving to make a difference to health systems around the globe.
“I’m honoured to join the FINN Global Health Practice and work alongside colleagues who are equally committed to championing health innovation.”
Taylor-Roberts joins FINN at a time of strong momentum for the Global Health Practice, led by Fern Lazar, Managing Partner.
The practice continues to experience rapid growth across EMEA, North America, and Asia, fueled by rising demand for integrated health communications, patient-centered brand strategy, and its presence on four continents.
Taylor-Roberts has built strong partnerships with life sciences companies, ranging from biotech and medical devices to large multinational pharmaceutical firms.
Sophie Taylor-Roberts
Her background in science, combined with her strategic communication skills, enables her to guide organisations through product launches, regulatory milestones, reputation building, and trust cultivation.
With more than 20 years of experience in health communications, Taylor-Roberts has held senior positions at Good Relations, Hill+Knowlton Strategies (now Burson) and Red Consultancy.
Most recently, she served as Managing Director, Healthcare UK at Hill+Knowlton Strategies, where she led the division through a substantial period of growth, delivering integrated, award-winning campaigns for clients including GSK, Haleon, Takeda and Roche.
Her career has been defined by a commitment to advancing health equity, patient engagement and operational excellence.
Fern Lazar, Managing Partner, Global Health Practice Lead, FINN Partners, said: “Sophie brings an exceptional blend of strategic insight, leadership acumen and a proven track record of client successes.
“Her experience in building high-performing teams and delivering breakthrough communications for health innovation clients will be a tremendous asset as we continue to expand our health capabilities across the UK and Ireland.”
Gil Bashe, Chair Global Health and Purpose, added:“Sophie brings her proven combination of strategic clarity, creative courage and human-centered leadership to our growing UK Health Group and the FINN Global Health Practice.
“Her experience across the health industry spectrum—from pharma and biotech to healthtech to advocacy and access—equips our clients with the foresight and flexibility that health transformation need to succeed.”
